InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the full record of transactions filed by Cullen Michael T., Director. Officer active across 1 company, notably Panbela Therapeutics, Inc.. Cumulatively, 2 reports have been recorded. Breakdown: 1 buy · 0 sell. History available since 25 May 2021. The latest transaction was disclosed on 25 May 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Cullen Michael T.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
165,000 sharesCommon StockSEC:0001437749-22-023776:0
Canonical exit: 2 Jan 2023 (T+90)
4,316 shares0Common StockSEC:0001437749-21-013591:0
2 of 2 declarations
About Cullen Michael T.
Michael T. Cullen is a Board Member at Panbela Therapeutics, Inc. He plays a crucial role in the strategic direction of the company, which focuses on developing cancer treatments. His experience helps guide critical decisions for the company's future.
